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ABSTRACT
Introduction: Outcomes of hip arthroscopy for femoroacetabular impingement and 
concomitant moderate- to advanced hip osteoarthritis (Tönnis Grade II or greater) 
is still a matter of debate as findings in the literature are controversial. This study 
aims to investigate whether hip arthroscopy is effective in treating patients with 
femoroacetabular impingement and Tönnis hip osteoarthritis Grade II or greater.
Methods and Analysis: The protocol follows the PRISMA-P guidelines. The systematic 
review is registered in the International Prospective Register for Systematic Reviews and 
Meta-analysis (PROSPERO) under the registration number: CRD42020210936. The search 
will include multiple databases: MEDLINE, EMBASE, Web of Science Core Collection and 
Cochrane library. The screening and selection process will be performed by two independent 
researchers based on predefined criteria. All studies published in English or German from 
inception to 1st of December 2020 that investigated outcomes of hip arthroscopy in 
patients with Tönnis grade II or greater of hip osteoarthritis will be considered eligible. The 
risk of bias and quality of articles will be assessed using the MINORS tool. Methodological 
inconsistency and heterogeneity will be explored using the I2 test. This assessment will be 
used to provide recommendations using the GRADE system.
Ethics and Dissemination: Separate ethical approval is not required. This study will 
be a comprehensive and rigorous systematic review on all published articles reporting 
on outcomes of hip arthroscopy for femoroacetabular impingement and concomitant 
hip osteoarthritis Tönnis Grade II or greater. It will explore patient reported outcomes 
as well as radiological outcomes, complications, rates of revision surgery and rates 
of conversion to total hip replacement (THR). Results of the current review will be 
published in a peer-reviewed scientific journal and disseminated on research platforms 
according to copyright rules and rights.
Highlights:
•	 Hip arthroscopy is used to treat femoroacetabular impingement and is effective in 
patients that have concomitant hip osteoarthritis Tönnis Grade 0 or 1.
•	 Outcomes of hip arthroscopy in patients with femoroacetabular impingement and in 
moderate to advanced osteoarthritis – Tönnis Grade 2 or greater, is a matter of debate.
•	 The purpose of the current systematic review is to elucidate, stratify and critical 
appraise the current evidence on outcomes in this patient subpopulation.
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1. INTRODUCTION
Femoroacetabular impingement (FAI) is a condition 
characterized by an abnormal hip morphology and 
represents an important cause of hip pain in young adults 
with an increasing interest worldwide [1, 2]. It is hypothe-
sized that femoroacetabular impingement may lead to 
earlier development of hip osteoarthritis (OA) [3]. FAI is 
treated either conservatively with activity-modification and 
physiotherapy [4] or with joint-preservation surgery, mainly 
hip arthroscopy (HA) or in specific cases, periacetabular 
osteotomies (PAO) or surgical hip dislocations [5]. The 
aim of such surgery is to reshape the hip joint to prevent 
impingement (abnormal mechanical contact) [6] and 
normalise stresses in the hip joint [7] and also address any 
concomitant extra-articular causes if present [8, 9]. Intra-
articular damage is addressed with debridement, repair or 
reconstruction in cases of labral tears, and a debridement 
or microfracture with different biological regenerative 
techniques in cases of articular cartilage damage [10]. It 
is now been well-reported, that HA is effective in achieving 
clinical improvement in patients with FAI and concomitant 
OA of Tönnis Grade I, demonstrated by the results of large 
scale multicentre randomized controlled trials (RCT): the 
UK FASHIoN (RCT) [11] and the FAIT trial [12].
However, outcomes for FAI and concomitant moderate- 
to advanced hip osteoarthritis (Tönnis Grade II or greater), 
for both hip arthroscopy or conservative regimens, is still 
a matter of intense debate as the best treatment remains 
controversial [13, 14]. As such, it is still unclear whether 
patients with FAI and signs of osteoarthritis would benefit 
from preservation surgery or should with conservative 
management or a joint replacement [5]. An important 
concern in young adults receiving a total hip replacement 
(THR), is the probability that they will most likely require 
multiple revisions in their lifetime [15], leaving the ultimate 
long-term outcome questionable. It is also unclear, what 
amount of OA can be managed with hip preservation 
techniques and which kind of surgery with what types of 
augmentation, should be employed. 
This study, therefore, aims to investigate whether 
hip arthroscopy is effective in treating patients with 
femoroacetabular impingement and concomitant Tönnis 
hip grade II OA or greater. 
2. METHODS AND ANALYSIS
2.1 STUDY DESIGN
The systematic review will follow The Preferred Reporting 
Items for Systematic Reviews and Meta-analysis – Protocol 
(PRISMA-P) guidelines [16]. The PRISMA statement 
will be used for the development of a flowchart of the 
systematic search. This systematic review is registered 
in the International Prospective Register for Systematic 
Reviews and Meta-analysis (PROSPERO) under the 
registration number: CRD42020210936.
2.2 SEARCH STRATEGY
Several databases will be searched, including: MEDLINE, 
EMBASE, Web of Science Core Collection and the Cochrane 
library. It is expected that about 50% of studies to be 
extracted from MEDLINE, whilst Web of Science Core 
Collection will cover the grey literature. Moreover, the 
reference lists will be searched at the full-text assessment 
stage. Articles published in English or German language from 
database inception to December 1st 2020 will be included. 
The search key-words will include studies looking at 
patients that underwent hip arthroscopy for the treatment 
of femoroacetabular impingement and concomitant hip 
osteoarthritis Tönnis Grade II or greater and will then be 
combined using the Boolean terms AND/OR. Combinations 
for each database using the following key-words will 
be used: “hip arthroscopy”, “FAI”, “femoroacetabular 
impingement” and “outcome”, “failure”, “results”.
2.3 STUDY SELECTION
A blinded and independent process of study selection 
based on title and abstract will be performed by two 
authors (OA and SK). Next, further selection based on 
predefined criteria will be performed by evaluating 
full texts. Studies will be screened according to the 
inclusion and exclusion criteria (Table 1). Review articles, 
surgical techniques, oral presentations, experimental or 
animal studies, studies mixing and overlapping patient 
populations will be excluded. The PICO tool has been used 
to formulate the research question. The participants will be 
young adults older than 16 years of age and younger than 
45 years of age. This will allow exclusion of the paediatric 
population where the growth plates may still be open [17] 
and where joint degeneration would be less likely to occur 
without secondary causes [18] and also of older patients, 
where it is well-known, that age alone, is a negative 
predictive factor of the outcome of hip arthroscopy 
[19–20]. Participants with active inflammatory disease, 
neurological conditions, previous ipsilateral surgeries of 
the hip or osteonecrosis will be excluded.
2.4 DATA EXTRACTION
The selected articles will then be exported to the 
Mendeley reference manager software and all duplicates 
will be removed. The final number of included articles 
will then be assessed for full text review and data will 
be extracted based on a pre-determined set of variables. 
Two reviewers (AO and SK) will assess and screen and 
if there is any discrepancy, a third more senior reviewer 
(VK) will be invited to advice until consensus is achieved 
between all authors. Data will be extracted into Microsoft 
Excel v16.21 under the following headings: author, 
study setting (country and year), number of included 
hips, follow-up, gender, age, Body Mass Index (BMI), 
diagnosis, stage of disease, previous treatments, surgical 
technique, augmentation technique (if any), clinical 
outcome (with preoperative and postoperative results 
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where applicable), radiographic outcome, complications, 
revision rates, rates of conversion and time to joint 
resurfacing or total joint replacement (THR). 
2.5 DATA ANALYSIS AND SYNTHESIS
The risk of bias and quality of studies will be evaluated 
using the MINORS criteria [21] (Methodological index 
for non-randomized studies) for each study design due 
to its rigor in assessing the methodological integrity 
of studies and also due to the retrospective nature of 
studies that exist in the literature. The process will be 
performed independently by two reviewers (AO and 
SK) and the senior author will be consulted in case no 
consensus is reached (VK). MINORS criteria assess eight 
critical aspects of study design for non-comparative 
clinical studies and an additional four aspects of study 
design for comparative clinical studies. Each item is 
given a score of zero if information is not reported, one 
if information is reported but inadequate, and two if 
information is reported and adequate. Therefore, the 
maximum possible score is 16 for comparative studies 
and 24 for non-comparative studies. Each score was 
then converted into a percentage to harmonise the 
scoring system.
Based on the scoring on quality assessment, the cumula-
tive confidence in evidence from all the data collected 
will be assessed using the Grading of Recommendations 
Assessment, Development and Evaluation (GRADE) 
system to inform recommendations [22].
Furthermore, an additional quality assessment for 
studies reporting on biological augmentation, mainly 
with MSCs (mesenchymal stem cells) will be performed 
using the MIBO tool [23] (Minimum Information for 
Studies Evaluating Biologics in Orthopaedics). A scoring 
system was then used per study such as studies that 
answered yes to a question from the checklist scored 2, 
not clear scored 1 and no scored 0. Each score was then 
converted into a percentage to harmonise the scoring 
system.
The statistical analysis will be performed using Review 
Manager (RevMan Cochrane) and Comprehensive Meta-
Analysis Software (CMA). Extraction and comparison will 
be performed by two authors independently (OA, SK). 
Any discrepancy will be consulted with the last author 
(VK) until an agreement will be reached.
For further quantification of methodological 
inconsistency and heterogeneity across studies, a I² 
test will be performed, with a p-value of p = 0.10. Values 
more than 40% are considered significant for moderate 
heterogeneity and over 75% are considered to be highly 
heterogeneous. This will assess whether observed 
differences in results are compatible with chance alone.
Depending on the heterogeneity, a random-effects-
model will be used for the meta-analysis if I² will be not 
significant, p > 0.1, otherwise, a fixed-effect model will 
be employed. Meta-analysis will be performed if the level 
of evidence of included studies will allow such analysis. 
If possible, outcomes will be longitudinally assessed 
at different timepoints of follow-up postoperatively: 6 
months, 12 months and 24 months.
Two subgroup analysis will be performed based on 
the scores achieved on quality assessment and based 
on disease stage, respectively. Studies will be separately 
analysed in two groups: those that achieved more than 
50% using MINORS and those that achieved 50% or less. 
The second subgroup analysis will stratify the outcomes 
based on preoperative disease stages: FAI with Tönnis ≤I 
versus FAI with Tönnis ≥II.
3. DISCUSSION
Femoroacetabular impingement (FAI) has a significant 
negative economic impact [24]. Patients affected by 
the pathological process are usually young and are in 
the most economically productive period of their life. 
Therefore, being debilitated by the condition and being 
treated conservatively or with surgical management 
after unsuccessful non-operative treatment has a great 
impact on productivity [25, 26]. 
Hip arthroscopy has been shown to reduce the 
substantial economic burden on patients suffering from 
INCLUSION CRITERIA EXCLUSION CRITERIA
•	 Study Design: Original articles in English or German language
•	  Population: patients with femoroacetabular impingement and 
Tönnis grade of hip osteoarthritis II or greater. Patients older 
than 16 years of age and younger than 45 years of age. Sample 
size equal or greater to 10 hips
•	  Intervention: Hip arthroscopy alone as the only intervention 
without open surgery
•	  Comparators: Patients with FAI with either Tönnis ≤I that 
received hip arthroscopy or with Tönnis ≥II that received any 
type of conservative treatment
•	  Outcomes: Patient reported outcomes, rates of conversion 
to total hip replacement (THR), complications, radiological 
outcomes. Minimum follow-up of 6 months
•	  Study Design: Review articles, surgical techniques, oral 
presentations, experimental or animal studies. Articles not 
written in English or German
•	  Population: Patients with osteonecrosis or post-avascular 
necrosis sequelae (Perthes), slipped capital femoral epiphysis, 
inflammatory or septic arthritis, previous surgery on the 
ipsilateral hip
•	 Intervention: Intervention included adjunct open procedure
Table 1 Inclusion and Exclusion Criteria based on PICO tool.
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FAI through indirect cost savings in a patient cohort in 
the United States of America [24]. Reports have shown 
that a rehabilitation of 3 months to 1 year is required to 
achieve an improvement compared to the baseline pre-
operative state, with however, some remaining deficits in 
activity [27, 28]. 
However, the efficacy of hip arthroscopy as a treatment 
option for patients with femoroacetabular impingement 
and concomitant hip OA remains a challenging subject 
without clear answers. The amount of degenerative 
changes that are already present and would preclude 
any benefits from surgery, are still to be elucidated. The 
purpose of this study is to determine whether moderate to 
advanced pre-operative concomitant OA precludes benefit 
of hip arthroscopy by systematically reviewing the literature 
on outcomes of hip arthroscopy for FAI in the setting of OA.
It is already known that there is a beneficial role of 
hip arthroscopy in patients with mild OA in terms of 
patient reported outcomes, as reported by two large 
scale multicentre randomized controlled trials [11, 12].
Furthermore, contraindications for hip arthroscopy due 
to poor outcomes have been previously described: less 
than 2 mm of joint space and Tönnis grade III changes 
[14, 29]. However, this leaves the patient cohort with 
FAI and Tönnis Grade II OA or greater, and literature is 
filled with contradictory outcomes and the debate on the 
best way of managing this cohort of patients continues 
[13, 30]. Domb and colleagues [30] have systematically 
reviewed the data and reported a 23% conversion rate 
to THR among patients with hip OA compared with 8.3% 
among patients without OA at a mean follow-up of 32 
months (range, 24 to 54 months). Supporting these 
findings, the same authors reported a 41% conversion 
rate to THR in their patient cohort with grade II Tönnis 
changes compared with a 11% conversion rate to THR at 
2 years among patients with grade 0 and I Tönnis OA [31]. 
Opposed to these results, Byrd et al. stated no differences 
in terms of conversion to THR between patients with FAI 
and Tönnis grade 0 and I of OA versus grade II changes 
at 2 years postoperatively [32]. A latter study from the 
same group, reported successful clinical outcomes even 
in the presence of Tönnis grade II radiographic features 
[13]. Procedural success of arthroscopic management of 
FAI seems to be less dependent on the technical aspects 
of performing the procedure and more substantially 
dependent on patient selection and expectations [19].
The strengths of our study will be represented by 
rigorous methodology and selection criteria reported 
in line with international standards [16]. Appropriate 
quality assessment will allow objective evaluation of the 
evidence level. There will be a tenacious stratification 
based on stage of the disease even in the presence of 
a variety of terminology to report on joint degeneration 
and cartilage damage. 
This systematic review will be the first step in a series of 
studies that will try to elucidate the most optimal treatment 
protocol and patient selection in the management of 
patients with FAI and concomitant moderate to advanced 
hip osteoarthritis in the young adult.
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